Tethys Investments focuses on lower-middle-markets and undertakes growth and distressed-assets investing in Eurasia. We don't invest in industries and companies where we don't know the mechanics and potential of value creation. We consider debt and equity capital options for identified great-value investments. Our investment decision making framework in Eurasia is based on 4 key tenets: (1) regional and country specialization, (2) industry expertise, & (3) rigorous due diligence including quantitative investment analysis & (4) field intensive qualitative analysis. We seek investment opportunities that result in stronger companies that employ the best people in the industry and region, are socially responsible, and deliver strong returns over the long-term. Whenever our analysis demonstrates viable exit options within 5-10 year term, Tethys Investments can invest in greenfield projects.
Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
Septeo
Private Equity Round in 2024
Septeo Group specializes in providing legal technology services to notaries, law firms, corporate legal departments, and real estate property managers. The company offers a range of solutions, including infrastructure management, digital communication, enterprise resource planning (ERP) software, managed cloud services, and outsourcing facilities. By delivering relevant tools and services, Septeo aims to simplify operations for its clients, allowing them to concentrate on their core business activities. The organization is structured to enhance the expertise of each company within the group, ensuring exceptional service delivery to its customers.
The Row
Private Equity Round in 2024
The ROW is a New York-based organization that specializes in designing, manufacturing, and providing a diverse range of ready-to-wear clothing and accessories. The company focuses on offering high-quality products, including ready-to-wear apparel, eyewear, handbags, and footwear for women, men, and children. Known for its emphasis on fine fabrics and an ideal fit, The ROW aims to deliver stylish and sophisticated options to its customers.
Sezane
Venture Round in 2022
Sezane Manufacturer of clothes and accessories in France.
Ceva Santé Animale
Venture Round in 2020
Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
M2i Life Sciences
Private Equity Round in 2019
M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.